A cap-dependent endonuclease inhibitor acts as a potent antiviral agent against La Crosse virus infection
Sign Up to like & getrecommendations! Published in 2025 at "Antimicrobial Agents and Chemotherapy"
DOI: 10.1128/aac.00186-25
Abstract: ABSTRACT La Crosse virus (LACV) infection, the causative agent of La Crosse encephalitis, can lead to severe neurological symptoms and sequelae, particularly in children. Despite annual reports of neurologically symptomatic cases, no effective treatment has… read more here.
Keywords: crosse; cap dependent; infection; crosse virus ... See more keywords